Progress in health-related quality-of-life scales applied in patients with mild stroke

GAO Yang; WANG Yue; XU Siyi; LI Gang

doi:10.12022/jnnr.2017-0063

PDF(1632 KB)

Journal of Neurology and Neurorehabilitation ›› 2017, Vol. 13 ›› Issue (4) : 197-203. DOI: 10.12022/jnnr.2017-0063

Review

Progress in health-related quality-of-life scales applied in patients with mild stroke

GAO Yang, WANG Yue, XU Siyi, LI Gang

Author information +

History +

Abstract

Stroke is a kind of cerebrovascular disease with high disability and high mortality, and 80% of ischemic stroke patients suffer from a mild stroke, which can cause neurological impairment and lower quality of life. Choosing the appropriate assessment scale is helpful to evaluate the quality of life of patients and guide the clinical practice. Currently, internal consistency and test-retest reliability are often used in the reliability analysis of the scales, and content validity and construct validity are often used in validity analysis. This paper reviews the definition, treatment and the presentations of impaired quality of life of mild stroke and the advances in application of health-related quality-of-life scales in patients with mild stroke.

Key words

Stroke, mild / Quality of life / Scales

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations

GAO Yang, WANG Yue, XU Siyi, LI Gang. Progress in health-related quality-of-life scales applied in patients with mild stroke[J]. Journal of Neurology and Neurorehabilitation. 2017, 13(4): 197-203 https://doi.org/10.12022/jnnr.2017-0063

References

[1] YU AY, HILL MD, COUTTS SB. Should minor stroke patients be thrombolyzed? A focused review and future directions[J]. Int J Stroke, 2015, 10(3):292-297.
[2] FISCHER U, BAUMGARTNER A, ARNOLD M, et al. What is a minor stroke?[J]. Stroke, 2010, 41(4):661-666.
[3] PARK TH, HONG KS, CHOI JC, et al. Validation of minor stroke definitions for thrombolysis decision making[J]. J Stroke Cerebrovasc Dis, 2013, 22(4):482-490.
[4] National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke[J]. N Engl J Med, 1995, 333(24):1581-1587.
[5] 倪金迪, 李　响, 刘　梅,等. 脑卒中及短暂性脑缺血发作的二级预防指南核心内容（2014年AHA/ASA版）[J]. 中国临床神经科学, 2015, 23(1):65-73.
[6] KENNEDY J, HILL MD, RYCKBORST KJ, et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial[J]. Lancet Neurol, 2007, 6(11):961-969.
[7] WANG Y, PAN Y, ZHAO X, et al. Clopidogrel with aspirin in acute minor stroke or transient ischemic attack (CHANCE) trial: one-tear outcomes[J]. Circulation, 2015,132(1):40-46.
[8] ALI SF, SIDDIQUI K, AY H, et al. Baseline predictors of poor outcome in patients too good to treat with intravenous thrombolysis[J]. Stroke, 2016, 47(12):2986-2992.
[9] HUANG Q, MA Q, JIA J, et al. Intravenous thrombolysis for minor stroke and rapidly improving symptoms: a quantitative overview[J]. Neurol Sci, 2014, 35(9):1321-1328.
[10] DONKOR ES, OWOLABI MO, BAMPOH PO, et al. Profile and health-related quality of life of Ghanaian stroke survivors[J]. Clin Interv Aging, 2014, 9:1701-1708.
[11] SANGHA RS, CAPRIO FZ, ASKEW R, et al. Quality of life in patients with TIA and minor ischemic stroke[J]. Neurology, 2015, 85(22):1957-1963.
[12] MUREN MA, HüTLER M, HOOPER J. Functional capacity and health-related quality of life in individuals post stroke[J]. Top Stroke Rehabil, 2008, 15(1):51-58.
[13] VILLAIN M, SIBON I, RENOU P, et al. Very early social support following mild stroke is associated with emotional and behavioral outcomes three months later[J]. Clin Rehabil, 2017, 31(1):135-141.
[14] EDWARDS DF, HAHN M, BAUM C, et al. The impact of mild stroke on meaningful activity and life satisfaction[J]. J Stroke Cerebrovasc Dis, 2006, 15(4):151-157.
[15] FRIDE Y, ADAMIT T, MAEIR A, et al. What are the correlates of cognition and participation to return to work after first ever mild stroke?[J]. Top Stroke Rehabil, 2015, 22(5):317-325.
[16] BROOKS R. EuroQol: the current state of play[J]. Health Policy, 1996, 37(1):53-72.
[17] PINTO EB, MASO I, VILELA RN, et al. Validation of the EuroQol quality of life questionnaire on stroke victims[J]. Arq Neuropsiquiatr, 2011, 69(2B):320-323.
[18] JANSSEN MF, PICKARD AS, GOLICKI D, et al. Measurement properties of the EQ-5D-5L compared to the EQ-5D-3L across eight patient groups: a multi-country study[J]. Qual Life Res, 2013, 22(7):1717-1727.
[19] GOLICKI D, NIEWADA M, BUCZEK J, et al. Validity of EQ-5D-5L in stroke[J]. Qual Life Res, 2015, 24(4):845-850.
[20] GOLICKI D, NIEWADA M, KARLI?SKA A, et al. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients[J]. Qual Life Res, 2014, 24(6):1555-1563.
[21] HUNT SM, MCKENNA SP, MCEWEN J, et al. The Nottingham Health Profile: subjective health status and medical consultations[J]. Soc Sci Med A, 1981, 15(3 Pt 1):221-229.
[22] CABRAL DL, DAMASCENA CG, TEIXEIRA-SALMELA LF, et al. Reliability of the Nottingham Health Profile after suffering a stroke[J]. Cien Saude Colet, 2012, 17(5):1313-1322.
[23] UNALAN D, SOYUER F, OZTURK A. Should the Nottingham Health Profile or the Short Form-36 be given preference in stroke?[J]. Neurosciences, 2009, 14(1):45-52.
[24] ANDERSON RT, AARONSON NK, WILKIN D. Critical review of the international assessments of health-related quality of life[J]. Qual Life Res, 1993, 2(6):369-395.
[25] 李　莉, 陈善佳, 方云华, 等. 中文版SF-36用于评价亚急性脑卒中患者生存质量的信度和效度[J].中国康复医学杂志, 2017, 32(5):509-515.
[26] ALMBORG AH, BERG S. Quality of life among Swedish patients after stroke: Psychometric evaluation of SF-36[J]. J Rehabil Med, 2009, 41(1):48-53.
[27] BERGNER M, BOBBITT RA, KRESSEL S, et al. The sickness impact profile: conceptual formulation and methodology for the development of a health status measure[J]. Int J Health Serv, 1976, 6(3):393-415.
[28] VAN STRATEN A, DE HAAN RJ, LIMBURG M, et al. Clinical meaning of the Stroke-Adapted Sickness Impact Profile-30 and the Sickness Impact Profile-136[J]. Stroke, 2000, 31(11):2610-2615.
[29] OWOLABI MO, OGUNNIYI A. Profile of health-related quality of life in Nigerian stroke survivors[J]. Eur J Neurol, 2009, 16(1):54-62.
[30] OJO OWOLABI M. HRQOLISP-26: a concise, multiculturally valid, multidimensional, flexible, and reliable stroke-specific measure[J/OL]. ISRN Neurol, 2011:295096(2011-12-06)[2017-10-24]. http://doi.org/10.5402/2011/295096.
[31] WILLIAMS LS. Health related quality of life outcomes in stroke[J]. Neuroepidemiology, 1998, 17(3):116-120.
[32] LO SH, CHANG AM, CHAU JP. Establishing equivalence of a Chinese version of the stroke specific quality of life measure for stroke survivors[J]. Disabil Rehabil, 2017, 39(11):1079-1086.
[33] MUUS I, CHRISTENSEN D, PETZOLD M, et al. Responsiveness and sensitivity of the Stroke Specific Quality of Life Scale Danish version[J]. Disabil Rehabil, 2011, 33(25-26):2425-2433.
[34] DUNCAN PW, WALLACE D, LAI SM, et al. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change[J]. Stroke, 1999, 30(10):2131-2140.
[35] VELLONE E, SAVINI S, FIDA R, et al. Psychometric evaluation of the Stroke Impact Scale 3.0[J]. J Cardiovasc Nurs, 2015, 30(3):229-241.

Funding

National Key Research and Development Program of The Ministry of Science and Technology (No. 2016YFA0101301); Academic Leader Training Program of Shanghai Pudong New District Health Bureau (No. PWRd2012-06)